Treatment Targets Not Met by Most Older Patients With Diabetes
Only one in three have diabetes controlled as defined by ADA guidelines
FDA Warns of Confusion Between Brintellix, Brilinta
No known use of the wrong drug, but prescribing, dispensing errors have been reported
LVEF Improvement for Many With Primary Prevention ICDs
Improvement for 40.0 percent of patients; improvement of more than 35 percent for 25 percent
Chocolate Consumption Shows No Impact on Risk of A-Fib
No association with incident atrial fibrillation; no evidence of effect modification by adiposity, age
New Drug Effectively Lowers Levels of Triglycerides
But it's not yet ready for standard care
2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years
Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
Early Invasive Strategy No Benefit 10 Years After NSTE-ACS
No improved outcomes versus selective invasive strategy in non-ST segment acute coronary syndrome
RAPID Score Validated for Prognosis of Pleural Infections
Recently developed score is valid for identifying mortality risk through five years in diverse cohort
Routine Dyspnea Severity Assessment Could Aid Care
Regular appraisal in cardiopulmonary disease patients would aid hospitalists' decision making
Atorvastatin/Ezetimibe Beats Atorvastatin After PCI
Combination therapy linked to greater coronary plaque regression in Japanese patients
